LONG-TERM DEBT (Tables)

12 Months Ended

Aug. 03, 2019

The Company’s long-term debt consisted of the following:



(in thousands)	Average Interest Rate at August 3, 2019	Calendar Maturity Year	August 3, 2019			July 28, 2018
Term Loan Facility	6.40%	2019-2025	$	1,864,900		$	—
ABL Credit Facility	3.58%	2023	1,080,000			—
Other secured loans	5.54%	2023-2024	57,649			—
Former ABL Credit Facility			—			210,000
Former Term Loan Facility			—			110,000
Debt issuance costs, net			(54,891		)	(1,164		)
Original issue discount on debt			(41,175		)	—
Long-term debt, including current portion			2,906,483			318,836
Less: current portion of long-term debt			(87,433		)	(10,000		)
Long-term debt			$	2,819,050		$	308,836

Schedule of Maturities of Long-term Debt

Future maturities of long-term debt, excluding debt issuance costs and original issue and purchase accounting discounts on debt, as of August 3, 2019, consist of the following:



Fiscal Year	(In thousands)
2020	$	102,713
2021	30,413
2022	31,091
2023	31,806
2024	1,105,526
2025 and thereafter	1,701,000
	$	3,002,549

Schedule of Line of Credit Facilities

The assets included in the Consolidated Balance Sheets securing the outstanding borrowings under the ABL Credit Facility on a first-priority basis, and the unused available credit and fees under the ABL Credit Facility, were as follows:



Assets securing the ABL Credit Facility (in thousands)⁽¹⁾:	August 3, 2019
Certain inventory assets included in Inventories and Current assets of discontinued operations	$	2,172,662
Certain receivables included in Accounts receivable, net and Current assets of discontinued operations	$	916,543


(1)	The ABL Credit Facility is also secured by all of the Company’s pharmacy scripts, which are included in Long-term assets of discontinued operations in the Consolidated Balance Sheets as of August 3, 2019.



Unused available credit and fees under the ABL Credit Facility (in thousands, except percentages):	August 3, 2019
Outstanding letters of credit	$	76,199
Letter of credit fees	1.375		%
Unused available credit	$	919,154
Unused facility fees	0.25		%